Aster peduncularis Wall. Ex. Nees: In- Vitro Antibacterial and Antileishmanial Activities of Essential oil from India

Bhawana Pant, Manisha Bisht, Devendra Singh DhamiResearch Square 2025 · DOI

This research paper explores the therapeutic potential of the essential oil (EO) derived from Aster peduncularis, a flowering plant native to the Himalayan region of India. The study demonstrates that this oil possesses significant antibacterial properties against both human and plant pathogens and shows promising activity against the parasite responsible for visceral leishmaniasis, all while remaining non-toxic to mammalian cells.

TL;DR

Researchers have found that the essential oil of the Himalayan plant Aster peduncularis acts as a potent antimicrobial agent against 11 different bacterial strains and effectively inhibits the growth of Leishmania donovani parasites. Crucially, the oil shows high selectivity, killing the parasites within host cells without damaging the host cells themselves, validating its traditional use in folk medicine.

What Problem Does This Paper Address?

The world is facing a dual crisis in infectious disease: the rise of multi-drug resistant (MDR) bacteria and a lack of safe, effective treatments for neglected tropical diseases like visceral leishmaniasis (Kala-azar). Current leishmaniasis treatments are often toxic, expensive, or facing increasing parasitic resistance.

While the genus Aster has been used in traditional medicine across Asia for centuries to treat everything from coughs to stomachaches, many species remain scientifically uncharacterized. This paper seeks to bridge the gap between traditional Himalayan ethnobotanical knowledge and modern pharmacology by rigorously testing the bioactivity of Aster peduncularis essential oil.

Methods

The researchers utilized a multi-pronged in vitro approach:

  • Extraction: Essential oil was extracted from fresh aerial parts of the plant via steam distillation.
  • Antibacterial Assays: The oil was tested against five human pathogens (including E. coli and P. aeruginosa) and six plant pathogens using standard disk diffusion (measuring zones of inhibition) and broth microdilution (to find the Minimum Inhibitory Concentration, or MIC).
  • Antileishmanial Assays: The team tested the oil against Leishmania donovani in two stages: the free-swimming promastigote stage and the clinically relevant intracellular amastigote stage (where the parasite lives inside host macrophages).
  • Cytotoxicity Testing: To ensure safety, they exposed the J774.A1 mouse macrophage cell line to the oil to check for cell deformation or death using Giemsa staining.

Datasets

As a biological study, the "datasets" consist of the specific microbial and parasitic strains used for evaluation:

  • Bacterial Panel: 11 strains including Salmonella typhimurium, Pseudomonas aeruginosa, and Xanthomonas phaseoli.
  • Parasite Strain: Leishmania donovani (Dd8).
  • Cell Line: J774.A1 (mouse macrophages) used as the host model for toxicity and intracellular infection.

Key Insights and Ideas

  • High Selectivity: One of the most significant findings is the oil's "therapeutic window." It was lethal to Leishmania parasites at concentrations that left the host macrophages completely unharmed. This selectivity is the "holy grail" of drug development.
  • Dual-Purpose Efficacy: The oil isn't just a human medicine; its high potency against plant pathogens like Xanthomonas phaseoli (MIC of 50 µl/ml) suggests it could potentially be developed into a natural, "green" pesticide for agriculture.
  • Validation of Folk Medicine: The study provides a scientific basis for the traditional use of Aster roots and aerial parts in Uttarakhand, India, for treating infections and stomach ailments.

Key Results

  • Antibacterial Power: The oil was most effective against the human pathogen P. aeruginosa (13.50 mm inhibition zone) and the plant pathogen X. phaseoli (18.50 mm inhibition zone).
  • Leishmania Inhibition: At a concentration of 100 µg/ml, the EO inhibited 84.04% of free-living promastigotes and 70.27% of the intracellular amastigotes.
  • Comparison to Standard Drugs: While the EO was effective, it required higher concentrations than the reference antibiotic (Streptomycin) and the antileishmanial drug (Miltefosine) to achieve similar results. However, as a complex natural mixture, it may be less prone to triggering rapid resistance than single-compound drugs.
  • Safety Profile: No cytotoxicity was observed in host macrophages even at the highest tested dose (100 µg/ml).

Limitations and Future Work

The primary limitation is that this study was conducted entirely in vitro (in a lab dish). While the results are promising, the complex environment of a living organism (in vivo) can change how a drug is metabolized or how well it reaches the site of infection.

Additionally, while the authors mention they previously reported the chemical composition of the oil in another paper, this specific study does not isolate which specific molecules (terpenes, phenols, etc.) are responsible for the activity. Future work should focus on identifying these active compounds and testing the oil's efficacy in animal models of infection.

Summary updated

Abstract

<title>Abstract</title> The study examined the antibacterial and antileishmanial properties of the essential oil extracted from <italic>Aster peduncularis </italic>Wall. Ex Nees. The antibacterial activity of this essential oil was studied using disk diffusion and broth microdilution methods on five human pathogen bacteria (<italic>Salmonella typhimurium(</italic>MTCC No.3224), <italic>Pseudomonas aeruginosa (</italic>MTCC No. 424), <italic>Bacillus subtilis (</italic>MTCC No. 441), <italic>Escherichia coli (</italic>MTCC No. 443), <italic>Klebsiella pneumoniae (</italic>MTCC No. 3348) and six plant pathogenic bacteria (<italic>Xanthomonas campestris(</italic>BB0006), <italic>Xanthomonas oryzae (</italic>BH0007), <italic>Ralstonia solanacearum (</italic>BI0012), <italic>Erwinia crysanthemi (</italic>KUMSCC 328), <italic>Xanthomonas phaseoli</italic> (KUMSCC 327), <italic>Agrobacterium tumefaciens (</italic>MTCC No. 609). The human bacterial strain <italic>P</italic>.<italic> aeruginosa</italic>was the most effective for oil (13.50 mm, MIC 75 µl/ml), followed by <italic>E</italic>.<italic>coli</italic> (13.05 mm, MIC 75 µl/ml), <italic>S</italic>.<italic> Typhimurium</italic> (10.40 mm, MIC 100 µl/ml), <italic>B</italic>.<italic> subtilis</italic> (10.20 mm, MIC 100 µl/ml) and <italic>K</italic>.<italic> pneumonia</italic> (10.20 mm, MIC 100 µl/ml). Among plant pathogens, <italic>X</italic>.<italic> phaseoli</italic> (18.50 mm, MIC 50 µl/ml) had the most potent antibacterial activity, followed by <italic>R</italic>.<italic> solanacearum</italic> (17.90 mm, MIC 50 µl/ml) and <italic>E</italic>.<italic> chrysanthem</italic>um (13.50 mm, MIC 75 µl/ml). We did the antileishmanial activity of essential oils with <italic>Leishmania donovani</italic> (Dd8) promastigotes and intracellular amastigotes. EO was safer on the J774.A1 macrophages and lethal to promastigotes and intracellular amastigotes at different concentrations (10, 50, and 100 µg/ml). These findings support the traditional uses of <italic>A. peduncularis</italic> and suggest its potential as a natural remedy for bacterial infections and leishmaniasis.
BibTeX
@inproceedings{pant2025aster,
  author = {Bhawana Pant and Manisha Bisht and Devendra Singh Dhami},
  title = {{Aster peduncularis Wall. Ex. Nees: In- Vitro Antibacterial and Antileishmanial Activities of Essential oil from India}},
  booktitle = {Research Square},
  year = {2025},
  doi = {10.21203/rs.3.rs-6288240/v1},
}
Figure